Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Burkitt Lymphoma 5Prostatic Neoplasms 4Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 2Hodgkin Disease 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Plasmablastic Lymphoma 1Neuroblastoma 1Lymphoma, T-Cell 1Lymphoma, Primary Effusion 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Leukemia, Biphenotypic, Acute 1Immunoblastic Lymphadenopathy 1HIV Infections 1Enteropathy-Associated T-Cell Lymphoma 1Composite Lymphoma 1Blast Crisis 1

Interventions

prednylidene 1pembrolizumab 1deltacortene 1Vincristine 1Rituximab 1Prednisone 1Doxorubicin 1Cyclophosphamide 1CT-P10 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Composite Lymphoma × prednylidene × Clear all
NCT02541565 2020-10-14

Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Diffuse Large B-cell Lymphoma or Grade 3b Follicular Lymphoma

University of Washington

Phase 1 Completed
30 enrolled 9 charts
Lymphoid

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Composite Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡